Concepedia

Barnaby Hunt

BH

48

Publications

1K

Citations

20

H-Index

2013

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Novo Nordisk (United Kingdom)

Novo Nordisk (United States)

Complejo Hospitalario Torrecárdenas

Örebro University

Barnaby Hunt is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacotherapy, and diabetes.

ORCID

Top concepts

Publications per year

2013–2023

48

Publications

48

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

Johan Jendle, Åsa Ericsson, Jens Gundgaard et al. · Diabetes Therapy · 2020 · 62 citations · Full text

Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme

Stephen C. Bain, Brian Bekker Hansen, Samuel J. P. Malkin et al. · Diabetes Therapy · 2019 · 50 citations · Full text

Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

Stephen C. Bain, Brian Bekker Hansen, Barnaby Hunt et al. · Journal of Medical Economics · 2019 · 48 citations · Full text

Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK

Adie Viljoen, C. S. Hoxer, Pierre Johansen et al. · Diabetes Obesity and Metabolism · 2018 · 44 citations · Full text

Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Failing Metformin Monotherapy in the United States

J Langer, Barnaby Hunt, William J. Valentine · Journal of Managed Care Pharmacy · 2013 · 40 citations · Full text

Rows per page

1–5 of 48